Orchestra BioMed Holdings, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Orchestra BioMed Holdings, Inc. (OBIO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.50M, a 22.92% decline year-over-year.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.85M, a 3.84% decline year-over-year.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.01M, a 27.45% increase year-over-year.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $3.25M, a 17.71% increase year-over-year.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $11.98M, a 12.84% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $10.62M, a 39.21% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $7.63M, a 125.93% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.38M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.50M 10-Q · filed 2026-08-10 | $5.36M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $2.85M 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | $11.98M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $3.01M 10-Q · filed 2025-11-10 | $6.26M derived: sum of 2 quarters · filed 2026-08-10 | $9.23M derived: sum of 3 quarters · filed 2026-08-10 | |
| 2025-06-30 | $3.25M 10-Q · filed 2026-08-10 | $6.21M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $2.96M 10-Q · filed 2026-08-10 | |||
| 2024-12-31 | $10.62M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $2.36M 10-Q · filed 2025-11-10 | $5.13M derived: sum of 2 quarters · filed 2025-11-10 | $7.71M derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | $2.76M 10-Q · filed 2025-11-10 | $5.35M derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | $2.59M 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $7.63M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $3.51M 10-Q · filed 2024-11-12 | $5.22M derived: sum of 2 quarters · filed 2024-11-12 | $6.71M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $1.71M 10-Q · filed 2024-11-12 | $3.20M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $1.49M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $3.38M 10-K · filed 2024-03-27 | |||
| 2022-09-30 | $2.22M 10-Q · filed 2023-11-13 | $2.44M derived: sum of 2 quarters · filed 2023-11-13 | $2.51M derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | $219.00K 10-Q · filed 2023-11-13 | $289.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | $70.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |